Free tool
Stocks above their 200-day average
We cover 39 companies trading above their own 200-day average. The median market value in the group is $19.07M. Across the group, the median move over the past trading day is +0.69%. 100% of the 39 with a 200-day average trade above it. Price change over the past year runs from −39.3% to +222.2% across the middle 80 percent of the group, with a median of +17.0%.
Other lists in this group
Table
39 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | $89.79M | Micro cap | −23.84% |
| SAR.L | Sareum Holdings plc | $70.10M | Micro cap | +76.19% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +265.03% |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | $67.16M | Micro cap | +1.97% |
| PRPO | Precipio, Inc. | $54.43M | Micro cap | +99.25% |
| OHGR.L | One Health Group Plc | $53.82M | Micro cap | +17.03% |
| ENP.AX | Entropy Neurodynamics Limited | $48.13M | Micro cap | +10.81% |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% |
| HBIO | Harvard Bioscience, Inc. | $34.83M | Micro cap | +44.34% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| SIGHT.PA | GenSight Biologics S.A. | $32.26M | Micro cap | −25.31% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | $27.48M | Micro cap | −44.31% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
| RENX.L | Renalytix Plc | $25.24M | Micro cap | −26.50% |
| RUA.L | RUA Life Sciences plc | $24.04M | Micro cap | +130.93% |
| ALTAO.PA | Aton | $22.75M | Micro cap | +153.85% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| PMI | Picard Medical, Inc. | $20.13M | Micro cap | +113.51% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +8660.74% |
| 5619.T | MRSO INC | $18.85M | Micro cap | −16.43% |
| LEXX | Lexaria Bioscience Corp. | $18.24M | Micro cap | +1146.05% |
| BCDA | BioCardia, Inc. | $18.02M | Micro cap | −38.66% |
| 7813.T | Platz Co., Ltd. | $17.74M | Micro cap | +18.51% |
| CMMB | Chemomab Therapeutics Ltd. | $16.85M | Micro cap | −25.57% |
| BTC.AX | BTC Health Limited | $15.67M | Micro cap | −1.61% |
| ICR.AX | Intelicare Holdings Limited | $14.91M | Micro cap | +75.76% |
| ICO.ST | Iconovo AB (publ) | $12.72M | Micro cap | −52.09% |
| CRTX.L | CRISM Therapeutics Corporation | $12.38M | Micro cap | +9.52% |
| APRE | Aprea Therapeutics, Inc. | $12.34M | Micro cap | −38.75% |
| LUCY | Lucyd, Inc | $9.73M | Micro cap | −42.05% |
| XBIO | Xenetic Biosciences, Inc. | $9.04M | Micro cap | +35.92% |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% |
| CURX | Curanex Pharmaceuticals Inc | $7.21M | Micro cap | −1.29% |
| IXC.AX | Invex Therapeutics Ltd | $7.00M | Micro cap | +30.00% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.48M | Micro cap | +211.51% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.48M | Micro cap | +93.92% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.